JP2011523549A5 - - Google Patents

Download PDF

Info

Publication number
JP2011523549A5
JP2011523549A5 JP2011508777A JP2011508777A JP2011523549A5 JP 2011523549 A5 JP2011523549 A5 JP 2011523549A5 JP 2011508777 A JP2011508777 A JP 2011508777A JP 2011508777 A JP2011508777 A JP 2011508777A JP 2011523549 A5 JP2011523549 A5 JP 2011523549A5
Authority
JP
Japan
Prior art keywords
subject
biomarkers
composite score
nsclc
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011508777A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011523549A (ja
JP5583117B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2009/000650 external-priority patent/WO2009137921A1/en
Publication of JP2011523549A publication Critical patent/JP2011523549A/ja
Publication of JP2011523549A5 publication Critical patent/JP2011523549A5/ja
Application granted granted Critical
Publication of JP5583117B2 publication Critical patent/JP5583117B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011508777A 2008-05-14 2009-05-14 非小細胞肺癌およびアジュバント化学療法に関する予後診断的および予測的な遺伝子シグネチャー Expired - Fee Related JP5583117B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7172808P 2008-05-14 2008-05-14
US61/071,728 2008-05-14
PCT/CA2009/000650 WO2009137921A1 (en) 2008-05-14 2009-05-14 Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy

Publications (3)

Publication Number Publication Date
JP2011523549A JP2011523549A (ja) 2011-08-18
JP2011523549A5 true JP2011523549A5 (enExample) 2012-07-05
JP5583117B2 JP5583117B2 (ja) 2014-09-03

Family

ID=41318311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011508777A Expired - Fee Related JP5583117B2 (ja) 2008-05-14 2009-05-14 非小細胞肺癌およびアジュバント化学療法に関する予後診断的および予測的な遺伝子シグネチャー

Country Status (6)

Country Link
US (3) US8211643B2 (enExample)
EP (1) EP2288741B1 (enExample)
JP (1) JP5583117B2 (enExample)
AU (1) AU2009246009A1 (enExample)
CA (1) CA2761571A1 (enExample)
WO (1) WO2009137921A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100184063A1 (en) * 2008-05-14 2010-07-22 Ming-Sound Tsao Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
AU2009246009A1 (en) 2008-05-14 2009-11-19 University Health Network Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
US20110238322A1 (en) * 2008-11-03 2011-09-29 Precision Therapeutics, Inc. Methods of simulating chemotherapy for a patient
CN101705306B (zh) * 2009-12-01 2012-07-11 华中农业大学 应用as-pcr检测牛尿苷酸合酶缺乏症的方法
US9607202B2 (en) 2009-12-17 2017-03-28 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of generating trophectoderm and neurectoderm from human embryonic stem cells
WO2011160118A2 (en) * 2010-06-18 2011-12-22 Med Biogene Inc. Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
US9200325B2 (en) * 2011-04-01 2015-12-01 Indiana University Research And Technology Corporation Diagnostic methods and kit for detecting cancer
PT2714926E (pt) * 2011-05-25 2015-11-03 Novartis Ag Biomarcadores para o cancro do pulmão
EP2739751A1 (en) * 2011-08-03 2014-06-11 Signal Pharmaceuticals, LLC Identification of gene expression profile as a predictive biomarker for lkb1 status
EP3563864A1 (en) 2013-01-18 2019-11-06 Kline, Ellis Selective glycosidase regimen for immune programming and treatment of cancer
CN104981697B (zh) 2013-02-11 2017-08-04 英丘伦有限责任公司 促染色质转录复合物(fact)在癌症中的用途
EP2971156B1 (en) 2013-03-15 2020-07-15 Myriad Genetics, Inc. Genes and gene signatures for diagnosis and treatment of melanoma
KR101830700B1 (ko) * 2013-11-11 2018-02-21 주식회사 파나진 클램핑 프로브 및 검출 프로브를 이용한 다중 표적핵산 검출방법
WO2015154064A2 (en) 2014-04-04 2015-10-08 Del Mar Pharmaceuticals Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
WO2016003810A1 (en) 2014-07-02 2016-01-07 Myriad Genetics, Inc. Genes and gene signatures for diagnosis and treatment of melanoma
JP7016466B2 (ja) * 2014-09-24 2022-02-07 国立研究開発法人国立がん研究センター 扁平上皮がんに対する化学放射線療法の有効性を評価するための方法
WO2016050623A1 (en) * 2014-09-29 2016-04-07 Institut Gustave Roussy Prognosis markers in lung cancer
CN106755309A (zh) * 2016-11-18 2017-05-31 北京致成生物医学科技有限公司 分子标记物在制备胰腺癌预后评估产品中的应用
JP7106810B2 (ja) * 2018-04-19 2022-07-27 学校法人 埼玉医科大学 新規肺がんマーカー
CN108949997A (zh) * 2018-08-24 2018-12-07 南京求臻基因科技有限公司 一种肺癌检测标志物及诊断试剂盒
CN109859801B (zh) * 2019-02-14 2023-09-19 辽宁省肿瘤医院 一种含有七个基因作为生物标志物预测肺鳞癌预后的模型及建立方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US7332590B2 (en) 2001-08-16 2008-02-19 The United States Of America As Represented By The Department Of Health And Human Services Molecular characteristics of non-small cell lung cancer
US20040241725A1 (en) * 2003-03-25 2004-12-02 Wenming Xiao Lung cancer detection
US20100184063A1 (en) * 2008-05-14 2010-07-22 Ming-Sound Tsao Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
AU2009246009A1 (en) 2008-05-14 2009-11-19 University Health Network Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy

Similar Documents

Publication Publication Date Title
JP2011523549A5 (enExample)
US20220396842A1 (en) Method for using gene expression to determine prognosis of prostate cancer
JP6351112B2 (ja) 前立腺癌の予後を定量化するための遺伝子発現プロフィールアルゴリズムおよび試験
CN103502473B (zh) 胃肠胰神经内分泌肿瘤(gep-nen)的预测
JP6404304B2 (ja) メラノーマ癌の予後予測
CN105431737B (zh) 用于预测局部晚期胃癌预后的系统
KR101672531B1 (ko) 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도
KR20130105764A (ko) 직장결장암용 예후 예측
WO2009114836A1 (en) Gene expression markers for prediction of patient response to chemotherapy
JP2008536488A5 (enExample)
EP2304631A1 (en) Algorithms for outcome prediction in patients with node-positive chemotherapy-treated breast cancer
WO2012040784A1 (en) Gene marker sets and methods for classification of cancer patients
CN101960022A (zh) Ⅱ期和ⅲ期结肠癌的分子分期和预后
US20180066321A1 (en) Gene expression panel for breast cancer prognosis
AU2017268510B2 (en) Method for using gene expression to determine prognosis of prostate cancer
WO2010104473A1 (en) A method for the systematic evaluation of the prognostic properties of gene pairs for medical conditions, and certain gene pairs identified
US20210102260A1 (en) Patient classification and prognositic method
WO2014130617A1 (en) Method of predicting breast cancer prognosis
CN114934117A (zh) 评价肺癌患者复发风险的产品
US20110287958A1 (en) Method for Using Gene Expression to Determine Colorectal Tumor Stage
WO2014130444A1 (en) Method of predicting breast cancer prognosis
Rhodes et al. Breast cancer companion diagnostic platform based on objectively defined tumor co-expression patterns stratifies multiple clinical and therapeutic endpoints comparison to existing molecular subtyping definitions